1. Home
  2. EYPT vs ARLO Comparison

EYPT vs ARLO Comparison

Compare EYPT & ARLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$13.35

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Arlo Technologies Inc.

ARLO

Arlo Technologies Inc.

HOLD

Current Price

$13.15

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
ARLO
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Consumer Electronics/Appliances
Sector
Industrials
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
EYPT
ARLO
Price
$13.35
$13.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$31.80
$24.00
AVG Volume (30 Days)
724.3K
1.4M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
145.16
EPS
N/A
0.13
Revenue
$7,539,000.00
N/A
Revenue This Year
N/A
$9.29
Revenue Next Year
$3,115.57
$8.82
P/E Ratio
N/A
$97.92
Revenue Growth
N/A
N/A
52 Week Low
$5.57
$11.05
52 Week High
$19.11
$19.94

Technical Indicators

Market Signals
Indicator
EYPT
ARLO
Relative Strength Index (RSI) 50.32 44.70
Support Level $12.66 $11.64
Resistance Level $13.32 $14.78
Average True Range (ATR) 0.74 0.78
MACD -0.03 -0.10
Stochastic Oscillator 58.08 20.59

Price Performance

Historical Comparison
EYPT
ARLO

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It combines a cloud infrastructure and mobile app with various smart connected devices to provide users with visibility, insight, and a means to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

Share on Social Networks: